Brief: Mesoblast Appoints Philip Facchina As Non-Executive Chair
02/01/2026 01:20
Jan 2 (Reuters) - Mesoblast Ltd MSB.AX: MESOBLAST ANNOUNCES CHANGES TO BOARD OF DIRECTOR ROLES PHILIP FACCHINA APPOINTED AS NON-EXECUTIVE CHAIR JANE BELL RETIRES AS CHAIR Further company coverage: MSB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast Reports QTRLY Ryoncil Net Revenues Of $30.3 Million
ASX-shares of Mesoblast rise after back-treatment drug hits patent target
Australia's Mesoblast soars on bagging licence for Mayo Clinic-developed tech
Brief: Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products
Brief: Mesoblast Says Ryoncil's Net Revenue For Quarter Increases To US$30.3M